Eventide Asset Management – NEUROCRINE BIOSCIENCES INC

Eventide Asset Management ownership history of NEUROCRINE BIOSCIENCES INC
QuarterValueSharesWeighting
Q1 2021$46,097
36.2%
474,000
34.3%
0.68%
31.6%
Q4 2020$33,835
-2.3%
353,000
-2.0%
0.52%
-23.5%
Q3 2020$34,637
-20.7%
360,200
0.7%
0.68%
-28.6%
Q2 2020$43,652
42.9%
357,800
1.4%
0.95%
-4.0%
Q1 2020$30,552
-19.5%
353,0000.0%0.99%
-7.5%
Q4 2019$37,944
19.3%
353,0000.0%1.07%
1.7%
Q3 2019$31,809
6.7%
353,0000.0%1.05%
16.0%
Q2 2019$29,804
25.3%
353,000
30.7%
0.91%
10.6%
Q1 2019$23,787
113.5%
270,000
73.1%
0.82%
66.1%
Q4 2018$11,140
-41.9%
156,0000.0%0.49%
-30.0%
Q3 2018$19,180
25.2%
156,0000.0%0.70%
10.7%
Q2 2018$15,325
18.5%
156,0000.0%0.64%
5.0%
Q1 2018$12,937
6.9%
156,0000.0%0.61%
-4.0%
Q4 2017$12,104
58.0%
156,000
24.8%
0.63%
45.4%
Q3 2017$7,660
33.2%
125,0000.0%0.43%
21.2%
Q2 2017$5,750
6.2%
125,0000.0%0.36%0.0%
Q1 2017$5,413
11.9%
125,0000.0%0.36%
13.7%
Q4 2016$4,838
-23.6%
125,0000.0%0.32%
-18.4%
Q3 2016$6,330
11.4%
125,0000.0%0.39%
10.9%
Q2 2016$5,681
14.9%
125,0000.0%0.35%
26.1%
Q1 2016$4,944
-30.1%
125,0000.0%0.28%
-21.8%
Q4 2015$7,071
-27.8%
125,000
-49.2%
0.35%
-38.0%
Q3 2015$9,792
35.4%
246,100
62.5%
0.57%
45.5%
Q2 2015$7,231
32.1%
151,400
9.9%
0.39%
-5.1%
Q1 2015$5,472
118.3%
137,800
22.8%
0.41%
50.4%
Q4 2014$2,507
65.6%
112,200
16.1%
0.27%
29.9%
Q3 2014$1,514
5.6%
96,6000.0%0.21%
8.2%
Q2 2014$1,434
2.0%
96,600
10.7%
0.20%
-10.6%
Q1 2014$1,406
290.6%
87,300
126.8%
0.22%
96.4%
Q4 2013$36038,5000.11%